首页> 美国卫生研究院文献>Vaccines >Oral Immunogenicity in Mice and Sows of Enterotoxigenic Escherichia Coli Outer-Membrane Vesicles Incorporated into Zein-Based Nanoparticles
【2h】

Oral Immunogenicity in Mice and Sows of Enterotoxigenic Escherichia Coli Outer-Membrane Vesicles Incorporated into Zein-Based Nanoparticles

机译:掺入玉米醇溶蛋白基纳米颗粒的产肠毒素大肠埃希菌外膜囊泡在小鼠和母猪中的口服免疫原性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Enterotoxigenic Escherichia coli (ETEC) strains are a major cause of illness and death in neonatal and recently weaned pigs. The immune protection of the piglets derives from maternal colostrum, since this species does not receive maternal antibodies through the placenta. In the present study, outer membrane vesicles (OMVs) obtained from main ETEC strains involved in piglet infection (F4 and F18 serotypes), encapsulated into zein nanoparticles coated with Gantrez AN-mannosamine conjugate, were used to orally immunize mice and pregnant sows. Loaded nanoparticles were homogeneous and spherical in a shape, with a size of 220–280 nm. The diffusion of nanoparticles through porcine intestinal mucus barrier was assessed by a Multiple Particle Tracking technique, showing that these particles were able to diffuse efficiently (1.3% diffusion coefficient), validating their oral use. BALB/c mice were either orally immunized with free OMVs or encapsulated into nanoparticles (100 µg OMVs/mouse). Results indicated that a single dose of loaded nanoparticles was able to elicit higher levels of serum specific IgG1, IgG2a and IgA, as well as intestinal IgA, with respect to the free antigens. In addition, nanoparticles induced an increase in levels of IL-2, IL-4 and IFN-γ with respect to the administration of free OMVs. Orally immunized pregnant sows with the same formulation elicited colostrum-, serum- (IgG, IgA or IgM) and fecal- (IgA) specific antibodies and, what is most relevant, offspring suckling piglets presented specific IgG in serum. Further studies are needed to determine the infection protective capacity of this new oral subunit vaccine
机译:产肠毒素的大肠杆菌(ETEC)菌株是新生和断奶仔猪疾病和死亡的主要原因。仔猪的免疫保护来自母初乳,因为该物种不通过胎盘接受母体抗体。在本研究中,从参与小猪感染的主要ETEC菌株(F4和F18血清型)获得的外膜囊泡(OMV)封装在包被Gantrez AN-甘露糖胺缀合物的玉米醇溶蛋白纳米颗粒中,用于口服免疫小鼠和母猪。负载的纳米颗粒是均匀的球形,形状为220-280 nm。通过多颗粒跟踪技术评估了纳米颗粒通过猪肠粘液屏障的扩散,表明这些颗粒能够有效地扩散(1.3%扩散系数),验证了它们的口服用途。用游离OMV口服免疫BALB / c小鼠,或将其封装到纳米颗粒中(每只小鼠100 µg OMV)。结果表明,相对于游离抗原,单剂量负载的纳米颗粒能够引发更高水平的血清特异性IgG1,IgG2a和IgA以及肠道IgA。另外,相对于游离OMV的施用,纳米颗粒诱导IL-2,IL-4和IFN-γ水平的增加。具有相同配方的口服免疫妊娠母猪会引发初乳,血清(IgG,IgA或IgM)和粪便(IgA)特异性抗体,最重要的是,后代哺乳仔猪的血清中也具有特异性IgG。需要进一步研究以确定这种新型口服亚单位疫苗的感染防护能力

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号